Personalized genomic medicine and prenatal genetic testing

JAMA - Journal of the American Medical Association

Volumn 312, Issue 12, 2014, Pages 1203-1205

  Dolan, Siobhan M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BRCA GENE; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 22Q11; COPY NUMBER VARIATION; DECISION SUPPORT SYSTEM; EDITORIAL; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HUMAN; MICROARRAY ANALYSIS; PERSONALIZED MEDICINE; PREGNANT WOMAN; PRENATAL SCREENING; RISK ASSESSMENT; SPONTANEOUS ABORTION; FEMALE; NOTE; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PREGNANCY; PRENATAL DIAGNOSIS;

DECISION SUPPORT TECHNIQUES; FEMALE; GENETIC TESTING; GUIDELINE ADHERENCE; HUMANS; PATIENT PARTICIPATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84907487890     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.12205     Document Type: Editorial

References (12)

1. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148(7):886-894.
2. American College of Obstetricians and Gynecologists. Committee opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol. 2013;122:1374-1377.
3. American College of Obstetricians and Gynecologists. Committee opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532-1534.
4. Kuppermann M, Pena S, Bishop JT, et al. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.11479.
5. Rapp R. Testing Women, Testing the Fetus. New York, NY: Routledge; 1999.
6. Klugman S, Suskin B, Spencer BL, et al. Clinical utility of chromosomal microarray analysis in prenatal diagnosis: report of first 6 months in clinical practice. J Matern Fetal Neonatal Med. 2014;27(13):1333-1338.
7. Bernhardt BA, Soucier D, Hanson K, Savage MS, Jackson L, Wapner RJ. Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med. 2013;15(2):139-145.
8. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175-2184.
9. American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217-227.
10. Edelman EA, Lin BK, Doksum T, et al. Implementation of an electronic genomic and family health history tool in primary prenatal care. Am J Med Genet C Semin Med Genet. 2014;166C(1):34-44.
11. O'Brien BM, Kloza EM, Halliday JV, Lambert-Messerlian GM, Palomaki GE. Maternal plasma DNA testing: experience of women counseled at a prenatal diagnosis center [published online August 19, 2014]. Genet Test Mol Biomarkers. doi:10.1089/gtmb.2014.0125
12. Phimister EG, Feero WG, Guttmacher AE. Realizing genomic medicine. N Engl J Med. 2012;366(8):757-759.